Clinical Lung Cancer
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Clinical Lung Cancer is a peer-reviewed medical journal that has been published by Elsevier since 2011. It was established by the CIG Media Group in 1999.
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherCIG MEDIA GROUP, LP
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1999
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 36% |
| 4-6 | 53% |
| 7-9 | 7% |
| >9 | 3% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Clinical Lung Cancer been publishing? 
The Clinical Lung Cancer has been publishing since 1999 till date.
How frequently is the Clinical Lung Cancer published?
Clinical Lung Cancer is published Bi-monthly.
Who is the publisher of Clinical Lung Cancer?
The publisher of Clinical Lung Cancer is CIG MEDIA GROUP, LP.
Where can I find a journal's aims and scope of Clinical Lung Cancer?
For the Clinical Lung Cancer's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Clinical Lung Cancer on editage?
For the Clinical Lung Cancer metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Clinical Lung Cancer?
The eISSN number is 1938-0690 and pISSN number is 1525-7304 for Clinical Lung Cancer.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Lung cancer, Anaplastic lymphoma kinase, Progression-free survival, Immunotherapy, Epidermal growth factor receptor, Overall survival, Chemoradiotherapy, Lung, Receptor tyrosine kinase, Exon, Multivariate analysis, Squamous cell lung cancer, Quality of life, Objective response, Concurrent chemoradiotherapy, Computed tomography, Positron emission tomography, Lymph node, Radiation Pneumonitis.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.